Cargando…

Expression of VEGF and Cox-2 in Patients with Esophageal Squamous Cell Carcinoma

Esophageal cancer is a highly aggressive neoplasm. In Brazil, it is the sixth most frequent among men and fifteenth among women. The most common type is squamous cell carcinoma (SCC), responsible for 96% of cases. Twenty-eight specimens of Esophael squamous cell carcinoma (ESCC) were obtained by sur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luz, Caio Cesar Floriano, Noguti, Juliana, Araújo, Leandro, Gomes, Thiago Simão, Mara, Gianni, Silva, Marcelo De Souza, Neto, Ricardo Artigiani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844614/ https://www.ncbi.nlm.nih.gov/pubmed/29373910 http://dx.doi.org/10.22034/APJCP.2018.19.1.171

Ejemplares similares

Hsp27 and Hsp70 Expression in Esophageal Squamous
por: Luz, Caio Cesar Floriano, et al.
Publicado: (2017)

VEGF as a Predictor for Response to Definitive Chemoradiotherapy and COX-2 as a Prognosticator for Survival in Esophageal Squamous Cell Carcinoma
por: Yoon, Mee Sun, et al.
Publicado: (2011)

GROWTH FACTORS AND COX2 IN WOUND HEALING: AN EXPERIMENTAL STUDY WITH EHRLICH TUMORS
por: SALGADO, Flávio L. L., et al.
Publicado: (2016)

Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway
Publicado: (2021)

EVALUATION OF P53, E-CADHERIN, COX-2, AND EGFR PROTEIN IMUNNOEXPRESSION ON PROGNOSTIC OF RESECTED GALLBLADDER CARCINOMA
por: PAIS-COSTA, Sergio Renato, et al.
Publicado: (2014)

Glucose-regulated protein 94 mediates progression and metastasis of esophageal squamous cell carcinoma via mitochondrial function and the NF-kB/COX-2/VEGF axis
por: Huang, Chien-Yu, et al.
Publicado: (2018)

Retraction: Corrigendum: Tan IIA Combined With DDP Inhibits Esophageal Squamous Cell Carcinoma via Down-Regulating the NF-kB/COX-2/VEGF Pathway
Publicado: (2021)

Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
por: Liao, Xiaozhong, et al.
Publicado: (2020)

Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett’s esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors
por: Carrossini, N., et al.
Publicado: (2021)

Parthenolide Inhibits Angiogenesis in Esophageal Squamous Cell Carcinoma Through Suppression of VEGF
por: Tian, Bo, et al.
Publicado: (2020)

Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
por: Liao, Xiaozhong, et al.
Publicado: (2021)

MET overexpression and intratumor heterogeneity in esophageal squamous cell carcinoma
por: Abboud, H.S., et al.
Publicado: (2021)

Mutations, Differential Gene Expression, and Chimeric Transcripts in Esophageal Squamous Cell Carcinoma Show High Heterogeneity()
por: Souza-Santos, Paulo Thiago de, et al.
Publicado: (2018)

Genetic Variants of EGF and VEGF Predict Prognosis of Patients with Advanced Esophageal Squamous Cell Carcinoma
por: Yang, Pei-Wen, et al.
Publicado: (2014)

Co-expression of VEGF-C and survivin predicts poor prognosis in esophageal squamous cell carcinoma
por: Zeng, Yun-Zhu, et al.
Publicado: (2021)

TFF1 hypermethylation and decreased expression in esophageal squamous cell carcinoma and histologically normal tumor surrounding esophageal cells
por: Gonzaga, Isabela Martins, et al.
Publicado: (2017)

The Involvement of β-Catenin/COX-2/VEGF Axis in NMDA-Caused Retinopathy
por: Ning, Dan, et al.
Publicado: (2017)

Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas
por: Gonzaga, Isabela Martins, et al.
Publicado: (2012)

Immunohistochemical expression of COX-2, Ki-67, Bcl-2, Bax, VEGF and CD105 according to histological grading in oral squamous cell carcinoma
por: Escobar, Enrico, et al.
Publicado: (2023)

Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer
por: Zhang, Xiao-Hua, et al.
Publicado: (2008)

COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
por: Timoshenko, A V, et al.
Publicado: (2006)

Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications
por: Gou, Hong-Feng, et al.
Publicado: (2011)

Clinical significance of COX-2, GLUT-1 and VEGF expressions in endometrial cancer tissues
por: Ma, Xiaoping, et al.
Publicado: (2015)

Improving VEGF-targeted therapies through inhibition of COX-2/PGE(2) signaling
por: Xu, Lihong, et al.
Publicado: (2014)

New insights into the functions of Cox-2 in skin and esophageal malignancies
por: Moon, Hyeongsun, et al.
Publicado: (2020)

Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma
por: Li, Jiangfen, et al.
Publicado: (2019)

The expression of COX-2 in VEGF-treated endothelial cells is mediated through protein tyrosine kinase.
por: Akarasereenont, Pravit C, et al.
Publicado: (2002)

Prognostic and predictive role of COX-2, XRCC1 and RASSF1 expression in patients with esophageal squamous cell carcinoma receiving radiotherapy
por: Zhang, Yaowen, et al.
Publicado: (2017)

COX-2 strengthens the effects of acid and bile salts on human esophageal cells and Barrett esophageal cells
por: Jiangang, Shen, et al.
Publicado: (2022)

HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium
por: Kurosu, T, et al.
Publicado: (2011)

Effect of VEGF-C siRNA and endostatin on ring formation and proliferation of esophageal squamous cell carcinoma lymphatic endothelial cells
por: Zheng, Yuping, et al.
Publicado: (2016)

The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy
por: Chen, Yen-Hao, et al.
Publicado: (2018)

Evaluation of VEGF expression correlates with COX-2 expression in pleomorphic adenoma, mucoepidermoid carcinoma and adenoid cystic carcinoma
por: Shamloo, Nafiseh, et al.
Publicado: (2020)

Correlation and significance of COX-2, Ki67, VEGF and other immune indexes with the growth of malignant pulmonary nodules
por: Guo, Haoxin, et al.
Publicado: (2022)

Evaluation of HIF-1α and VEGF-A expression in radiation-induced cystitis: A case-control study
por: de Mattos, Ricardo Castellani, et al.
Publicado: (2021)

DW-MRI for esophageal squamous cell carcinoma, correlations between ADC values with histologic differentiation and VEGF expression: A retrospective study
por: Cong, Qingxue, et al.
Publicado: (2019)

Expression of VEGF, EGF, and Their Receptors in Squamous Esophageal Mucosa, with Correlations to Histological Findings and Endoscopic Minimal Changes, in Patients with Different GERD Phenotypes
por: Wasielica-Berger, Justyna, et al.
Publicado: (2022)

Transcriptome Analysis Identifies ALCAM Overexpression as a Prognosis Biomarker in Laryngeal Squamous Cell Carcinoma
por: Nicolau-Neto, Pedro, et al.
Publicado: (2020)

Polymorphism in COX-2 modifies the inverse association between Helicobacter pylori seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study
por: Hu, Huang-Ming, et al.
Publicado: (2009)

Analysis of the correlation between P53 and Cox-2 expression and prognosis in esophageal cancer
por: CHEN, JUN, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_md0f2ipp9i8193q00266k5hqan